ethyl 5-chloro-3-methoxyindole-2-carboxylate | 153501-19-0

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吲哚及其衍生物
• 英文名称: ethyl 5-chloro-3-methoxyindole-2-carboxylate
• 英文别名: Ethyl 5-chloro-3-methoxy-1H-indole-2-carboxylate
• CAS: 153501-19-0
• 化学式: C₁₂H₁₂ClNO₃
• 分子量: 253.685
• InChiKey: QCGJCZHZOKEIBM-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.2
• 重原子数：
  17
• 可旋转键数：
  4
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.25
• 拓扑面积：
  51.3
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  ethyl 5-chloro-3-methoxyindole-2-carboxylate 在 copper diacetate 、 三溴化硼 、 三乙胺 作用下， 以 二氯甲烷 为溶剂， 反应 33.0h， 生成 1-(4-tert-Butyl-phenyl)-5-chloro-3-(4-chloro-3-trifluoromethyl-phenoxy)-1H-indole-2-carboxylic acid ethyl ester
  参考文献：
  名称：

  Synthesis and biological activities of novel aryl indole-2-carboxylic acid analogs as PPARγ partial agonists

  摘要：

  A series of novel aryl indole-2-carboxylic acids has been identified as potent selective PPAR gamma modulators. Their chemical synthesis and in vitro activities are discussed. Compound 5 was selected for in vivo testing in the db/db mouse model of type 2 diabetes and resulted in reduction of hyperglycemia at comparable plasma exposure when compared to rosiglitazone. (c) 2005 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2005.08.002
• 作为产物：
  描述：

  5-Chlor-2-methoxycarbonylmethylamino-benzoesaeuremethylester 以 甲醇 、 乙醚 为溶剂， 反应 2.0h， 生成 ethyl 5-chloro-3-methoxyindole-2-carboxylate
  参考文献：
  名称：

  Synthesis and biological activities of novel aryl indole-2-carboxylic acid analogs as PPARγ partial agonists

  摘要：

  A series of novel aryl indole-2-carboxylic acids has been identified as potent selective PPAR gamma modulators. Their chemical synthesis and in vitro activities are discussed. Compound 5 was selected for in vivo testing in the db/db mouse model of type 2 diabetes and resulted in reduction of hyperglycemia at comparable plasma exposure when compared to rosiglitazone. (c) 2005 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2005.08.002

文献信息

• Fused pyrrole derivatives
  申请人：Banner David

  公开号：US20070142452A1

  公开（公告）日：2007-06-21

  The invention is concerned with novel fused pyrrole derivatives of formula (I) wherein A, Ar, R 1 , R 2 , R 2′ and R 2″ and n are as defined in the description and in the claims, as well as physiologically acceptable salts thereof. These compounds inhibit chymase and can be used as medicaments.

  这项发明涉及式(I)的新型融合吡咯衍生物，其中A、Ar、R1、R2、R2′和R2″以及n的定义如描述和权利要求中所定义，并且其生理上可接受的盐。这些化合物抑制chymase并可用作药物。
• Synthesis, pharmacology and therapeutic potential of 10-methoxypyrazino[1,2-a]indoles, partial agonists at the 5HT2C receptor
  作者：M Bös、F Jenck、JR Martin、JL Moreau、V Mutel、AJ Sleight、U Widmer

  DOI：10.1016/s0223-5234(97)83976-1

  日期：1997.1

  A series of new 10-methoxypyrazino[1,2-a]indoles has been prepared and shown to be 5HT(2C) receptor ligands. The studied compounds 10a-j were found to act as partial agonists at the 5HT(2C) receptor, binding with high affinity and moderate selectivity versus 5HT(1A) and 5HT(2A) receptors, but inducing only a submaximal increase in phosphoinositol formation. Compound 10j was demonstrated to be active in animal models of obsessive-compulsive disorder, depression and panic anxiety.
• Evaluation of isotryptamine derivatives at 5-HT2 serotonin receptors
  作者：Jean Chang-Fong、James Addo、Małgorzata Dukat、Carol Smith、Nicholas A. Mitchell、Katharine Herrick-Davis、Milt Teitler、Richard A. Glennon

  DOI：10.1016/s0960-894x(01)00713-2

  日期：2002.1

  On the basis that meta-chlorophenylpiperazine (mCPP: 1) is a nonselective 5-HT2C agonist. that benz-fused tryptamines (e.g., 5) display enhanced 5-HT2 affinity, and that certain isotryptamines 3 reportedly bind with enhanced affinity and selectivity at 5-HT2C receptors, we prepared and examined a series of isotryptamine-related analogues as potentially selective 5-HT2C agonists. None of the compounds displayed selectivity for 5-HT2C versus 5-HT2A receptors. Detailed re-examination of a compound previously reported to display 100-fold 5-HT2C selectivity [i.e.. S(+)-5,6-aifluoro-alpha-methylisotryptamine] revealed that its selectivity versus 5-HT2A receptors was, at best. only 10-fold. (C) 2002 Elsevier Science Ltd. All rights reserved.
• NOVEL FUSED PYRROLE DERIVATIVES
  申请人：F.HOFFMANN-LA ROCHE AG

  公开号：EP1966134A1

  公开（公告）日：2008-09-10
• US7696240B2
  申请人：——

  公开号：US7696240B2

  公开（公告）日：2010-04-13